Skip to main content
SpringerLink
Log in

Organische Störungen, Demenzen

  • Chapter
Handbuch der Psychopharmakotherapie

  • 2571 Accesses

Auszug

Das Primat bei organischen Störungen ist die Diagnostik der Grunderkrankung und, wenn möglich, die kausale Therapie derselben. Die Therapie kann je nach Diagnose von einem vollständig kurativen Ansatz bis hin zur palliativen Verlangsamung der Krankheitsprogression und Linderung der Primärsymptomatik bzw. Hilfen zur Kompensation eingetretener Defizite reichen. Die symptomorientierte Psychopharmakotherapie hat hierbei ein breites Anwendungsspektrum, muss jedoch dabei innerhalb der spezifischen Rahmenbedingungen der jeweiligen kausalen Therapie vermeiden, durch neu eingebrachte Nebenwirkungen oder Wechselwirkungen den Behandlungserfolg zu gefährden.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 99.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  • Albin RL, Minoshima S, D’Amato CJ, Frey KA, Kuhl DA, Sima A (1996) Fluoro-deoxyglucose positron emission tomography in diffuse Lewy body disease. Neurology 47: 462–446

    PubMed  CAS  Google Scholar 

  • American Psychiatric Association (1999) Practice guidelines for the treatment of patients with delir lum. Am J Psychiatry 5(156 (Suppl 5): 1–20

    Google Scholar 

  • Areosa Sastre A, Grimley Evans J (2003) Effect of the treatment of Type II diabetes mellitus on the development of cognitive impairment and dementia. Cochrane Database of Syst Revl: CD003804

    Google Scholar 

  • Attala N, Cruccua G, Haanpa M et al (2006) EFNS guidelines on pharmacological treatment of neuropathic pain. Eur J Neurol 13: 1153–1169

    Article  Google Scholar 

  • AWMF (Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften) (2005) Leitlinien für Diagnostik und Therapie in der Neurologie, 3. Aufl. Thieme, Stuttgart

    Google Scholar 

  • AWMF (Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften) (2006) Internetseite fachübergreifende Leit-linien: http://leitlinien.net oder http://www.uni-duesseldorf.de/ awmf/

  • Batty MJ et al (2006) Relaxation strategies and enhancement of hypnotic susceptibility: EEG neurofeedback, progressive muscle relaxation and self hypnosis. Brain Res Bull 71(1–3): 83–90

    Article  PubMed  Google Scholar 

  • Basbaum AI, Fields HL (1984) Endogenous pain control systems: brain-stem spinal pathways and endorphin circuitry. Ann Rev Neurosci 7: 309–338

    Article  PubMed  CAS  Google Scholar 

  • Berry N, Sagar R, Tripathi BM (2003) Catatonia and other psychiatric symptoms with vitamin B12 deficiency. Acta Psychiatr Scand 108: 156–159

    Article  PubMed  CAS  Google Scholar 

  • Birks J (2006) Cholinesterase inhibitors for Alzheimer’s disease (review). Cochrane Database Syst Rev: CD005593

    Google Scholar 

  • Birks J, Harvey R (2003) Donepezil for dementia due to Alzheimer’s disease. Cochrane Database Syst Rev: CD001190

    Google Scholar 

  • Birks J, Grimley Evans J, Iakovidou V et al (2000) Rivastigmine for Alzheimer’s disease. Cochrane Database Syst Rev: CD001191

    Google Scholar 

  • Birks J, Grimley EV, Van Dongen M (2002) Ginkgo biloba for cognitive impairment and dementia. Cochrane Database Syst Rev: CD003120.

    Google Scholar 

  • Black SE (1996) Focal cortical atrophy syndromes. Brain Cogn 31: 188–229

    Article  PubMed  CAS  Google Scholar 

  • Boeve BF, Lang AE, Litvan I (2003) Corticobasal degeneration and its relationship to progressive supranuclear palsy and frontotemporal dementia. Ann Neurol 54: S15–S19

    Article  PubMed  Google Scholar 

  • Bonelli RM, Wenning GK, Kapfhammer HP (2004) Huntington’s disease. Present treatments and future therapeutic modalities. Int Clin Psychopharmacol 19: 51–62

    Article  PubMed  Google Scholar 

  • Byrne EJ, Burns A, Waite J (1992) Neuroleptic sensitivity in dementia with cortical Lewy bodies. Br Med J 305: 1158–1159

    CAS  Google Scholar 

  • Casserly I, Topol E (2004) Convergence of atherosclerosis and Alzheimer’s disease: inflammation, cholesterol, and misfolded proteins. Lancet 363: 1139–1146

    Article  PubMed  CAS  Google Scholar 

  • Chen KM, Tseng WS, Ting LF, Huang GF (2007) Development and evaluation of a yoga exercise programme for older adults. J Adv Nurs 57(4): 432–441

    Article  PubMed  Google Scholar 

  • Chong, JY, Rowland LP, Utiger RD (2003) Hashimoto encephalopathy: syndrome or myth? Arch Neurol 60: 164–171

    Article  PubMed  Google Scholar 

  • Chow TW, Miller BL, Hayashi VN, Geschwind DH (1999) Inheritance of frontotemporal dementia. Arch Neurol 56: 817–822

    Article  PubMed  CAS  Google Scholar 

  • Colloby S, O’Brien J (2004) Functional imaging in Parkinson’s disease and dementia with Lewy bodies. J Geriatr Psychiatry Neurol 17: 158–163

    Article  PubMed  Google Scholar 

  • Craig D, Birks J. (2004) Rivastigmine for vascular cognitive impairment. Cochrane Database Syst Rev 2: CD004744

    Google Scholar 

  • Craig D, Birks J (2006) Galantamine for vascular cognitive impairment. Cochrane Database Syst Rev 1: CD004746

    Google Scholar 

  • Craighead WE, Hart AB, Craighead LW (2002) Psychosocial treatments for major depressive disorder. In: Nathan P, Gorman JM (eds) A guide to treatments that work. Oxford University Press, New York, pp 245–261

    Google Scholar 

  • Cummings JL, Masterman DL (1999) Depression in patients with Parkinson’s disease. Int. J. Geriat Psychiatry 14: 711–718

    Article  CAS  Google Scholar 

  • Dantoine T, Auriacombe S, Sarazin M et al (2006) Rivastigmine montherapy and combination therapy with memantine in patients with moderately severe Alzheimer’s disease who failed to benefit from previous cholinesterase inhibitor treatment. Int J Clin Practice 60: 110–118

    Article  CAS  Google Scholar 

  • Davies S, Ramsden DB (2001) Huntington’s disease. Mol Pathol 54: 409–413

    PubMed  CAS  Google Scholar 

  • De Deyn PP, Buitelaar J (2006) Risperidone in the management of agitation and aggression associated with psychiatric disorders. Eur Psychiatry 21: 21–28

    Article  PubMed  Google Scholar 

  • Del Ser T, Hachinski V, Merskey H, Munoz DG (2001) Clinical and pathological features of two groups of patients with dementia with Lewy Bodies: effect of coexisting Alzheimer-type lesion load. Alzheimer Dis Assoc Disord 15: 31–44

    Article  PubMed  Google Scholar 

  • deLeon J, Antelo RE, Simpson G (1992) Delusion od parasitosis or chronic tactile hallucinosis: hypothesis about their brain physiopathology. Compr Psychiatry 33(1): 25–33

    Article  CAS  Google Scholar 

  • Dichgans M, Mayer M, Uttner I et al (1998) The phenotypic spectrum of CADASIL: clinical findings in 102 cases. Ann Neurol 44: 731–739

    Article  PubMed  CAS  Google Scholar 

  • Dihel J, Ernst J, Krapp S, Förstl H, Nedopil N, Kurz A (2006) Misdemeanor in frontotemporal dementia. Fortschr Neurol Psychiat 74: 203–210

    Article  Google Scholar 

  • Dilling H, Mombour W, Schmidt MH (Hrsg) (2005) Weltgesundheitsorganisation. Internationale Klassifikation psychischer Störungen ICD-10 Kapitel V (F) Klinisch-Diagnostische Leitlinlen, 5. Aufl. Huber, Bern

    Google Scholar 

  • Eichenberg C (2006) Internet-Recherche zu psychischen Erkrankungen im Alter. Informationen für Experten, Betroffene und Angehörige. Eine Auswahl von Webseiten zu Gerontopsychologie und-psychiatrie. Dtsch Ärztebl 4: 174–176

    Google Scholar 

  • Emre M, Aarsland D, Albanese A et al (2004) Rivastigmine for dementia associated with Parkinson’s disease. N Engl J Med 351: 2509–2518

    Article  PubMed  CAS  Google Scholar 

  • Esmonde T, Liles E, Gibson M, Hodges JR (1996) Neuropsychological performance, disease severity, and depression in progressive supranuclear palsy. Neurol 243: 638–673

    Article  CAS  Google Scholar 

  • Fick DM, Cooper JW, Wade WE, Waller JL, Maclean JR, Beers MH (2003) Updating the Beers criteria for potentially inappropriate medication use in older adults: results of a US consensus panel of experts. Arch Intern Med 163: 2716–2724

    Article  PubMed  Google Scholar 

  • Fishbain DA et al (2004) Do the second-generation »atypical neuroleptics« have analgesic properties? A structured evidence-based review. Pain Med 5(4): 359–365

    Article  PubMed  Google Scholar 

  • Flicker L, Grimley Evans J (2004) Piracetam for dementia or cognitive impairment. Cochrane Database Syst Rev 1: CD001011

    Google Scholar 

  • Foster NL, Gilman S, Berent S et al (1992) Progressive subcortical gliosis and progressive supranuclear palsy can have similar clinical and PET abnormalities. J Neurol Neurosurg Psychiatry 55: 707–713

    PubMed  CAS  Google Scholar 

  • Friedman JH, Berman RM, Goetz CG et al (2006) Open-label flexible-dose pilot study to evaluate thesafety and tolerability of aripiprazole in patients with psychosis associated with Parkinson’s disease. Mov Disord 21(12): 2078–2081

    Article  PubMed  Google Scholar 

  • Gill SS, Bronskill SE, Normand SLT et al (2007) Antipsychotic drug use and mortality in older adults with dementia. Ann Int Med 146(11): 775–786

    PubMed  Google Scholar 

  • Gilron I et al (2006) Neuropathic pain: a practical guide for the clinician. CMAJ 175(3):265–275

    PubMed  Google Scholar 

  • Glickman N (2007) Do you hear voices? Problems in assessment of mental status in deaf persons with severe language deprivation. J Deaf Stud Deaf Education 12(2): 127–147

    Article  Google Scholar 

  • Gomez-Esteban C, Zarranz JJ et al (2005) Use of Ziprasidone in parkinsonian patients with psychosis. Clin Neuropharmacol 28(5): 254

    Google Scholar 

  • Goodnick PJ (2001) Use of antidepressants in treatment of comorbid diabetes mellitus and depression as well as in diabetic neuropathy. Ann Clin Psychiatry 13(1): 3–41

    Article  Google Scholar 

  • Gräber MB, Müller U (2003) Dementia with Lewy bodies: disease concept and genetics. Neurogenetics 4: 147–162

    Google Scholar 

  • Gralow I (2002) Cancer pain: an update to pharmacological approaches in pain therapy. Curr Opinion Anaesthesiol 15: 555–561

    Article  Google Scholar 

  • Greicius MD, Geschwind MD, Miller BL (2002) Presenile dementia syndromes: an update on taxonomy and diagnosis. J Neurol Neurosurg Psychiatry 72: 691–700

    Article  PubMed  CAS  Google Scholar 

  • Griffiths TD (2000) Musical hallucinosis in acquired deafness — phenomenology and brain substrate. Brain 123: 2065–2076

    Article  PubMed  Google Scholar 

  • Grimes DA, Lang AE, Bergeron CB (1999) Dementia as the most common presentation of cortico-basal ganglionic degeneration. Neurology 53: 1969–1974

    PubMed  CAS  Google Scholar 

  • Grossberg GT, Edwards KE and Zhao Q (2006) Rationale for combination therapy with galatamine and memantine in Alzheimer’s disease. J Clin Pharmacol 46: 17–26

    Article  CAS  Google Scholar 

  • Hagelberg N et al (2003) Altered dopamine D2 receptor binding in atypical facial pain. Pain 106: 43–48

    Article  PubMed  CAS  Google Scholar 

  • Hála M (2007) Pathophysiology of postoperative delirium: systemic inflammation as a response to surgical trauma causes diffuse microcirculatory impairment. Med Hypotheses 68(1): 194–196

    Article  PubMed  Google Scholar 

  • Hamrick I, Mertens U, Lippert H, Meyer F (2006) Delir und Demenz im perioperativ-chirurgischen Management. Zentralbl Chir 131: 62–68

    Article  PubMed  CAS  Google Scholar 

  • Hanen J, Klimek L, Hofmann K (2005) Pharmacological management of allergic rhinitis in the elderly: safety issues with oral anthistamines. Drugs Aging 22(4): 289–296

    Article  Google Scholar 

  • Hartmann S, Mobius HJ (2003) Tolerability of memantine in combination with cholinesterase inhibitors in dementia therapy. Int Clin Psychopharmacol 18: 81–85

    Article  PubMed  Google Scholar 

  • Higgins JPT, Flicker L (2000) Lecithin for dementia and cognitive impairment. Cochrane Database Syst Rev 4: CD001015

    Google Scholar 

  • Hirsch JA, Gibson GE (1984) Selective alteration of neurotransmitter release by low oxygen in vitro. Neurochem Res 9(8): 1039–1049

    Article  PubMed  CAS  Google Scholar 

  • Hodges JR, Garrard P, Patterson K (1998) Semantic dementia. In: Kertexz A, Munoz DG (eds) Pick’s disease and Pick complex. Wiley-Liss, New York, pp 83–104

    Google Scholar 

  • Hofman A, Ot A, Breteler MM et al (1997) Atherosclerosis, apolipoprotein E, and prevalence of dementia and Alzheimer’s disease in the Rotterdam Study. Lancet 349: 151–154

    Article  PubMed  CAS  Google Scholar 

  • Holm KJ, Markham A (1999) Mirtazapine—a review of its use in major depression. Drugs 57(4): 607–631

    Article  PubMed  CAS  Google Scholar 

  • Hopkins RO, Jackson JC (2006) Long-term neurocognitive function after critical illness. Chest 1130: 869–878

    Article  Google Scholar 

  • Hu XS, Okamura N, Arai H et al (2000) 18F-fluorodopa PET study of striatal dopamine uptake in the diagnosis of dementia with Lewy bodies. Neurology 55: 1575–1576

    PubMed  CAS  Google Scholar 

  • Ikeda M, Shigenobu K, Fukuhara R et al (2004) Efficacy of fluvoxamine as a treatment for behavioural symptoms in frontotemporal lobar degeneration patients. Dement Ge riatr Co gn Disord 17: 117–121

    Article  CAS  Google Scholar 

  • Ince PG, Perry EK, Morris CM (1998) Dementia with Lewy bodies. A distinct non-Alzheimer dementia syndrome? Brain Pathol 8: 299–324

    Article  PubMed  CAS  Google Scholar 

  • Inouye SK (2006) Current concepts: deliriumin older persons. N Engl J Med 354(11): 1157–1165

    Article  PubMed  CAS  Google Scholar 

  • Jain KK (2001) Drug-induced seizures. In: Jain KK (ed) Drug-induced neurological disorders. Hogrefe & Huber Seattle

    Google Scholar 

  • Johnson JK, Diehl J, Mendez MF et al (2005) Frontotemporal lobar degeneration: demographic characteristics of 353 patients. Arch Neurol 62: 925–930

    Article  PubMed  Google Scholar 

  • Kane J, Canas F, Kramer M, Ford L, Gassmann-Mayer C, Lim P, Eerdekens M (2007) Treatment of schizophrenia with paliperidone extended-release tablets: a 6-week placebo-controlled trial. Schiz Res 90(1–3): 147–161

    Article  CAS  Google Scholar 

  • Karlsson I (1999) Drugs that induce delirium. Dement Geriatr Cogn Disord 10: 412–415

    Article  PubMed  CAS  Google Scholar 

  • Knopman DS, Rocca WA, Cha CH et al (2003) Survival study of vascular dementia in Rochester, Minnesota. Arch Neurol 60: 85–90

    Article  PubMed  Google Scholar 

  • Knopman DS, Petersen RC, Edland SD, Cha RH, Rocca WA (2004) The incidence of frontotemporal lobar degeneration in Rochester, Minnesota, 1990 through 1994. Neurology 62: 506–508

    PubMed  CAS  Google Scholar 

  • Kosaka K, Yoshimura M, Ikeda K, Budka H (1980) A cliniconeuropathological study of the »Lewy body disease«. Seishan Shinkeigaku Zasshi 82: 292–311

    CAS  Google Scholar 

  • Krismer M et al (2007) Strategies for prevention and management of musculoskeletal conditions. Best Pract Res Clin Rheumatol 21(1): 77–91

    Article  PubMed  CAS  Google Scholar 

  • Kurz AF (2005) Uncommon neurodegenerative causes of dementia. Int Psychogeriatr 17(Suppl): S35–S49

    Article  PubMed  Google Scholar 

  • Kwekkeboom KL, Gretarsdottir E (2006) Systematic review of relaxation interventions for pain. J Nurs Scholarsch 38(3): 269–277

    Article  Google Scholar 

  • Lautenschlager NT, Almeida OP (2006) Physical activity and cognition in old age. Curr Opin Psychiatry 19: 190–193

    Article  PubMed  Google Scholar 

  • Lautenschlager NT, Martins RN (2005) Common versus uncommon causes of dementia. Int Psychogeriatr 17(Suppl): S27–S34

    Article  PubMed  Google Scholar 

  • Le Bars PL, Berman N, Iltl TM, Freedman AM, Freedman AM, Schatzberg AF (1997) A placebo-controlled, double-blind, randomized trial of an extract of Ginkgo biloba for dementia. North American EGb Study Group. JAMA 278: 1327–1332

    Google Scholar 

  • Lee PE, Gill SS, Freedman M, Bronskill SE, Hillmer MP, Rochon PA (2004) Atypical antipsychotic drugs in the treatment of behavioural and psychological symptoms of dementia: systematic review. Br Med J 329(7457): 75

    Article  Google Scholar 

  • Leentjens AFG, van der Mastb RC (2005) Delirium in elderly people: an update. Curr Opin Psychiatry 18: 325–330

    Article  PubMed  Google Scholar 

  • Leentjens AFG, Diefenbacher A (2006) A survey of delirium guidelines in Europe. J Psychosomat Res 61: 123–128

    Article  Google Scholar 

  • Liperoti R, Pedone C, Lapane KL, Mor V, Bernabei R, Gambassi G (2005) Venous thromboembolism among elderly patients treated with atypical and conventional antipsychotic agents. Arch Intern Med 165: 2677–2682

    Article  PubMed  Google Scholar 

  • Litvan I, Agid Y, Calne D et al (1996) Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP international workshop. Neurology 47: 1–9

    PubMed  CAS  Google Scholar 

  • Litvan I, Agid Y, Goetz C et al (1997) Accuracy of the clinical diagnosis of corticobasal degeneration: a clinicopathologic study. Neurology 48: 119–125

    PubMed  CAS  Google Scholar 

  • Loeb C, Meyer JS (1996) Vascular dementia: still a debatable entity? J Neurol Sci 143: 31–40

    Article  PubMed  CAS  Google Scholar 

  • Lopez-Meza E, Rulz-Chow A, Ramirez-Bermudez J (2005) Aripiprazole in psychosis associated with Parkinson’s disease. J Neuropsychiatry Clin Neurosci 17: 421–422)

    PubMed  CAS  Google Scholar 

  • Lyness JM, Cox C, Curry J, Conwell Y, King DA, Caine DE (1995) Older age and the underreporting of depressive symptoms. J Am Geriatr Soc 43: 216–221

    PubMed  CAS  Google Scholar 

  • Mach JR, Dysken MW, Kuskowski M et al (1995) Serum anticholinergic activity in hospitalized older persons with delirium: a preliminary study. J Am Geriatr Soc 43: 491–495

    PubMed  Google Scholar 

  • Majumdar SK (1990) Chlormethiazole: current status in the treatment of the acute ethanol withdrawal syndrome. Drug Alcohol Depend 27: 201–207

    Article  Google Scholar 

  • Malouf R, Birks J (2004) Donepezil for vascular cognitive impairment. Cochrane Database Syst Rev 1: CD004395

    PubMed  Google Scholar 

  • Marriott RG, Neil W, Waddingham S (2006) Antipsychotic medication for elderly people with schizophrenia (review). The Cochrane Collaboration in: Cochrane Database Syst Rev 1: CD005580

    Google Scholar 

  • McGuiness B, Todd S, Passmore P, Bulock R (2006) Blood pressure lowering in patients without prior cerebrovascular disease for prevention of cognitive impairment and dementia. Cochrane Database Syst Rev: CD004034

    Google Scholar 

  • McKeith, IG, Ballard CG, Harrison RW (1995) Neuroleptic sensitivity to risperidone in Lewy body dementia. Lancet 346: 699

    Article  PubMed  CAS  Google Scholar 

  • McKeith IG, Galasko D, Kosaka K et al (1996) Consensus guidelines for the Clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. Neurology 47: 1113–1124

    PubMed  CAS  Google Scholar 

  • McKeith IG, Del Ser T, Spano P et al (2000) Efficacy of rivastigmine in dementia with Lewy bodies: a randomised, double-blind, placebo-controlled international study. Lancet 356: 2031–2036

    Article  PubMed  CAS  Google Scholar 

  • McKeith IG, Mintzer J, Aarsland D et al (2004) Dementia with Lewy bodies. Lancet Neurol 3; 19–28

    Article  PubMed  Google Scholar 

  • McKeith IG, O’Grien J et al; DLB Study Group (2007) Sensitivity and specificity of dopamine transporter imaging with 123I-FP-CIT SPECT in dementia with Lewy bodies: a phaselll, multicentre study. Lancet Neurol 6: 305–313

    Article  PubMed  Google Scholar 

  • Mico JA et al (2006) Antidepressants and pain. Trends Pharm Sci 27(7): 348–354

    Article  PubMed  CAS  Google Scholar 

  • Miyasaki JM, Shannon K, Voon V et al (2006) Practice parameter: evaluation and treatment of depression, psychosis, and dementia in Parkinson disease (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 66: 996–1002

    Article  PubMed  CAS  Google Scholar 

  • Mendez MF, Ghajarania M, Perryman KM (2002) Posterior cortical atrophy: clinical characteristics and differences compared to Alzheimer’s disease. Dement Geriatr Cogn Disord 14: 33–40

    Article  PubMed  Google Scholar 

  • Micieli M (2006) Vascular dementia. Neurol Sci 27: S37–S39

    Article  PubMed  Google Scholar 

  • Möbius HJ, Stöffler A (2002) New approaches to clinical trials in vascular dementia: memantine in small vessel disease. Cerebrovasc Dis 13(Suppl 2): 61–66

    PubMed  Google Scholar 

  • Morone NE, Greco CM (2007) Mind-body interventions for chronic pain in older adults: a structured review. Pain Med 8(4):359–375

    Article  PubMed  Google Scholar 

  • Neuropathology Group Medical Research Council Cognitive Function and Aging Study (2001) Pathological correlation of late-onset dementia in a multicentre, community-based-population in England and Wales. Lancet 357: 169–175

    Article  Google Scholar 

  • Nestor PJ, Caine D, Fryer TD, Clarke J, Hodges JR (2003) The topography of metabolic deficits in posterior cortical atrophy (the visual variant of Alzheimer’s disease). J Neurol Neurosurg Psychiatry 74: 1521–1529

    Article  PubMed  CAS  Google Scholar 

  • Potter NT, Spector EB, Prior TW (2004) Technical standards and guidelines for Huntington disease testing. Genet Med 6(1): 61–65

    Article  PubMed  Google Scholar 

  • O’Callaghan CC (1996) Pain, music creativity and music therapy in palliative care. Am J Hosp Palliat Care 13(2): 43–49

    Article  Google Scholar 

  • Oechsner M, Korchounov A (2005) Parenteral ziprasidone: a new atypical for emergency treatment of psychosis in Parkinson’s disease? Hum Psychopharmacol Clin Exp 20: 203–205

    Article  Google Scholar 

  • Osborn DPJ, Nazareth I, King MB (2006) Risk for coronary heart disease in people with severe mental illness. Cross-sectional comparative study in primary care. Br J Psychiatry 18(8): 271–277

    Article  Google Scholar 

  • Osborne TL, Raichle KA, Jensen MP (2006) Psychologic interventions for chronic pain. Phys Med Rehabil Clin N Am 17(2): 415–433

    PubMed  Google Scholar 

  • Passant U, Elfgren C, Englund E, Gustafson L (2005) Psychiatric symptoms and their psychosocial consequences in frontotemporal dementia. Alzheimer Dis Assoc Disord 19(Suppl 1): S15–S18

    Article  PubMed  Google Scholar 

  • Perriol MP, Krystkowlak P, Defebvre L, Blond S, Deste’e A, Dujardin K (2006) Stimulation of the subthalamic nucleus in Parkinson’s disease: cognitive and affective changes are not linked to the motor outcome. Parkinsonism Related Disord 12: 205–210

    Article  Google Scholar 

  • Phillips EM, Bodenheimer CF, Roig RL, Cifu DX (2004) Geriatric rehabilitation. 4. Physical medicine and rehabilitation interventions for common age-related disorders and geriatric syndromes. Arch Phys Med Rehabil 85(Suppl 3): 18–22

    Article  Google Scholar 

  • Pratt RR (2004) Art, dance and music therapy. Phys Med Rehabil Clin N Am 15(4): 827–841

    PubMed  Google Scholar 

  • Rabheru K, Persad E (1997) A review of continuation and maintenance electro-convulsive therapy. Can J Psychiatry 42(5): 476–484

    PubMed  CAS  Google Scholar 

  • Raffa RB et al (1992) Opioid and nonopioid components independently contribute to the mechanism of action of tramadol, an atypical opioid analgesic. J Pharmacol Exp Ther 26: 275–285

    Google Scholar 

  • Raivio MM, Laurila JV, Strandberg TE, Tilvis RS, Pitkala KH (2007) Neither atypical nor conventional antipsychotics increase mortality or hospital admissions among elderly patients with dementia: a two-year prospective study. Am J Geriatr Psychiatry 15(5): 416–424

    Article  PubMed  Google Scholar 

  • Rands G, Orrel M, Spector A (2000) Aspirin for vascular dementia. Cochrane Database Syst Rev 4: CD001296

    PubMed  Google Scholar 

  • Raskin J et al (2006) Duloxetine versus routine care in the long-term management of diabetic peripheral neuropathic pain. J Palliative Med 9(1): 29–40

    Article  Google Scholar 

  • Renner JA, Burns HJM, Hou CE, McKeel DW, Storandt M, Morris JC (2004) Progressive posterior cortical dysfunction: a clinicopathologic series. Neurology 63: 1175–1180

    PubMed  CAS  Google Scholar 

  • Riemenschneider M, Lautenschlager NT, Wagenpfeil S, Diehl J, Drzezga A, Kurz A (2002) Cerebrospinal fluid tau and ß-amyloid 42 proteins identify Alzheimer disease in subjects with mild cognitive impairment. Arch Neurol 59: 1729–1734

    Article  PubMed  CAS  Google Scholar 

  • Roman, GC, Tatemichi TK, Erkinjuntii T et al (1993) Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIR-EN International Workshop. Neurology 43: 250–268

    PubMed  CAS  Google Scholar 

  • Rovner BW (2006) The Charles Bonnet syndrome: a review of recent research. Curr Opin Ophtalmol 17: 275–277

    Article  Google Scholar 

  • Schneeweiss S, Wang PS (2007) Risk of death associated with the use of conventional versus atypical antipsychotic drugs among elderly patients. CMAJ 176(5): 627–632

    PubMed  Google Scholar 

  • Schneider LS, Dagerman K, Insel PS (2006) Efficacy and adverse effects of atypical antipsychotics for dementia: meta-analysis of randomized, placebo-controlled trials. Am J Geriatr Psychiatry 14(3): 191–210

    Article  PubMed  Google Scholar 

  • Schönfeldt-Lecuona C, Connemann B (2004) Aripiprazole and Parkinson’s disease psychosis. Am J Psychiatry 161: 373–374

    Article  PubMed  Google Scholar 

  • Schreiber S et al (1999) The atypical neuroleptics clozapine and olanzapine differ regarding their antinociceptive mechanisms and potency. Pharm Biochem Behav 64(1): 75–88

    Article  CAS  Google Scholar 

  • Sergeant N, Wattez A, Delacourte A (1999) Neurofibrillary degeneration in progressive supranuclear palsy and corticobasal degeneration: tau pathologies with exclusively »exon 10« isoforms. J Neurochem 72: 1243–1249

    Article  PubMed  CAS  Google Scholar 

  • Shah A (2006) Can risperidone and olanzapine in elderly patients with dementia and other mental disorders be discontinued? Int J Gerlatr Psychiatry 21: 140–146

    Article  Google Scholar 

  • Singh Ajit S (2007) Does aripiprazole have a role in treating cognitive impairment in Parkinson’s disease? J Neuropsychiatry Clin Neurosci 19(2): 205–206

    Google Scholar 

  • Smith AR (2007) Manual therapy: the his torical, current, and future role in the treatment of pain. Sci World J 2(7):109–120

    Google Scholar 

  • Sobrido MJ, Miller BL, Havlioglu N et al (2003) Novel tau polymorphisms, tau haplotypes, and splicing in familial and sporadic frontotemporal dementia. Arch Neurol 60, 698–702

    Article  PubMed  Google Scholar 

  • Tang-Wai DF, Graff-Redford NR, Boeve BF et al (2004) White matter loss in the splenium of the corpus callosum in a case of posterior cortical atrophy: a diffusion tensor imaging study. Eur Neurol 52: 77–81

    Article  Google Scholar 

  • Taylor NF et al (2007) Therapeutic exercise in physiotherapy practice is beneficial: a summary of systematic reviews 2002–2005. Aust J Physiother 53(1): 7–16

    PubMed  Google Scholar 

  • Tekin S, Cummings JL (2002) Frontal-subcortical neuronal circuits and clinical neuropsychiatry — an update. J Psychosom Res 53: 647–654

    Article  PubMed  Google Scholar 

  • The Lund and Manchester Groups (1994) Clinical and neuropathological criteria for frontotemporal dementia. J Neurol Neurosurg Psychiatry 57: 416–418

    Article  Google Scholar 

  • Theobald DE, Kirsh KL, Holtsclaw E, Donaghy K, Passik SD (2002) An open-label, crossover trial of mirtazapine (15 and 30 mg) in cancer patients with pain and other dis tressing symptoms. J Pain Symptom Management 23(5): 442–447

    Article  CAS  Google Scholar 

  • Trzepacz PT (2000) Is there a final common neural pathway in delirium? Focus on acetylcholine and dopamine. Semin Clin Neuropsychiatry 5: 132–148

    PubMed  CAS  Google Scholar 

  • Turk DC, Okifuji A, Scharff L (1995) Chronic pain and depression: role of perceived impact and perceived control in different age cohorts. Pain 61: 93–101

    Article  PubMed  CAS  Google Scholar 

  • Van Dyck CH, Schmitt FA, Olin JT (2006) A responder analysis of memantine treatment in patients with Alzheimer disease maintained on donepezil. Am J Geriatr Psychiatry 14: 238–437

    Article  Google Scholar 

  • Venesy DA (2007) Physical medicine and complementary approaches. Neurol Clin 25(2): 523–537

    Article  PubMed  Google Scholar 

  • Vernino S, Geschwind M, Boeve B (2007) Autoimmune encephalopathies. Neurologist 13(3): 140–147

    Article  PubMed  Google Scholar 

  • Wang PS, Schneeweiss S, Avorn J et al (2005) Risk of death in elderly users of conventional vs. atypical antipsychotic medications. N Engl J Med 353(22): 2335–2341

    Article  PubMed  CAS  Google Scholar 

  • Waegemans T, Wilsher CR, Danniau A, Ferris SH, Kurz A, Winblad B (2002) Clinical efficacy of piracetam in cognitive impairment: a meta-analysis. Dement Geriatr Cogn Discord 13: 217–224

    Article  CAS  Google Scholar 

  • Wetterling T, Kanitz RD, Borgis KJ (1996) Comparison of different diagnostic criteria for vascular dementia (ADDTC, DSM-IV, ICD-10, NINDS-AIREN). Stroke 27: 30–35

    PubMed  CAS  Google Scholar 

  • Wickremaratchi M, Morris HR (2005) Aripiprazole associated with severe exacerbation of Parkinson’s disease. Mov Disord 21(9): 1538

    Article  Google Scholar 

  • Wickramasakera I (1999) How does biofeedback reduce clinical symptoms and do memories and beliefs have biological consequences? Appl Psychophysiol Biofeedback 24(2): 91–105

    Article  Google Scholar 

  • Williamson GM, Schulz R (1992) Pain, activity restriction and symptoms of depression among community-residing elderly adults. J Gerontol 47: 367–372

    Google Scholar 

  • Zarranz JJ, Alegre J, Gomez-Esteban JC et al (2004) The new mutation E46K of α-synuclein causes Parkinson and Lewy body dementia. Ann Neurol 55: 164–173

    Article  PubMed  CAS  Google Scholar 

Download references

Authors
  1. Marion M. Lautenschlager
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Nicola T. Lautenschlager
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Hans Förstl
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Max-Planck-Institut für Psychiatrie, Kraepelinstraße 2-10, 80804, München

    Florian Holsboer

  2. Klinik für Psychiatrie und Psychotherapie, Universitätsklinikum der Rheinisch-Westfälischen Technischen Hochschule Aachen, Pauwelsstraße 30, 52074, Aachen

    Gerhard Gründer

  3. Ehemals: Psychiatrische Klinik und Poliklinik der Johannes-Gutenberg-Universität Mainz, Untere Zahlbacher Straße 8, 55131, Mainz

    Otto Benkert

Rights and permissions

Reprints and permissions

Copyright information

© 2008 Springer Medizin Verlag Heidelberg

About this chapter

Cite this chapter

Lautenschlager, M.M., Lautenschlager, N.T., Förstl, H. (2008). Organische Störungen, Demenzen. In: Holsboer, F., Gründer, G., Benkert, O. (eds) Handbuch der Psychopharmakotherapie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-68748-1_39

Download citation

  • DOI: https://doi.org/10.1007/978-3-540-68748-1_39

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-20475-6

  • Online ISBN: 978-3-540-68748-1

  • eBook Packages: Medicine (German Language)

Publish with us

Policies and ethics

Search

Navigation